Heidi Combs MD Assistant Professor Harborview Medical Center.
Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director,...
-
Upload
maura-blunden -
Category
Documents
-
view
214 -
download
2
Transcript of Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director,...
![Page 1: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/1.jpg)
Healthcare-Associated Infections and Infection Control
Timothy H. Dellit, MDMedical Director, Infection Control
Harborview Medical Center
![Page 2: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/2.jpg)
Patient Safety and Infection Control• Prevention, monitoring, and feedback
– Healthcare-associated infections• Catheter-associated bloodstream infections• Ventilator-associated pneumonia• Surgical site infections• Catheter-associated UTI
– Transmission of multidrug-resistant/marker organisms• MRSA• VRE• Carbapenem-resistant Acinetobacter• ESBL-producing organisms → MDR Enterobacteriaceae• C. difficile• Aspergillus in burn and immunocompromised populations• Tuberculosis
![Page 3: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/3.jpg)
Increasing Regulation and Reporting
• CMS and “preventable events”– FY2008
• Catheter-associated urinary tract infection• Vascular catheter-associated infections• Mediastinitis after CABG
– FY2009• SSI following select orthopedic procedures
– Spinal fusion– Elbow and shoulder arthroplasty
• SSI following bariatric surgery• Mandatory reporting of healthcare-associated infections (HB 1106)
– Central line infections in ICU: July 2008– Ventilator-associated pneumonia: January 2009– Selected surgical site infections: January 2010
• Cardiac surgery• Total hip and knee arthroplasty• Hysterectomy
CMS RHQDAPUFY2013-FY2015CLA-BSISSICA-UTICentral line bundle complianceMRSA bacteremiaC. difficileInfluenza vaccination of HCW
![Page 4: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/4.jpg)
![Page 5: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/5.jpg)
![Page 6: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/6.jpg)
“MDRO Bundle”
Increased Hand Hygiene Associated with Decreased MRSA Transmission
0
10
20
30
40
50
60
70
80
90
100
1994 1998
Han
d H
ygie
ne A
dher
ance
0
0.5
1
1.5
2
2.5
Tra
nsm
issi
on p
er 1
0,00
0 pa
tient
-day
sHand hygiene
MRSA Transmission rate
Lancet 2000;356:1307-12
• Hand Hygiene• Contact precautions• Minimize shared equipment• Environmental cleaning• Healthcare-associated
infections preventive bundles– Catheter-associated BSI– Ventilator-associated
pneumonia– Catheter-associated UTI– SCIP measures
• Active surveillance cultures • Chlorhexidine baths• Antimicrobial stewardship• Patient and staff education
![Page 7: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/7.jpg)
![Page 8: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/8.jpg)
0 20 40 60 80 100
Room Door Handle
IV Pump Button
Bath Door Handle
Side Rails
BP Cuff
Overbed Table
Patient Gown
Bed Linen
Percent of Surfaces Positive for MRSA
Infect Control Hosp Epidemiol 1997;18:622-627
Role of Environmental Contamination
0
10
20
30
40
50
60
70
80
90
100
Gowns Gloves
Contact with patient
Contact with environment
Contact Contamination
Per
cent
pos
itive
![Page 9: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/9.jpg)
Who are you sleeping with?
Arch Intern Med 2006;166:1945-1951
40% increased risk of transmission associated with prior occupant’s MRSA or VRE carriage
Infect Control Hosp Epidemiol 2011;32:201-6
![Page 10: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/10.jpg)
To Survey or Not to Survey?
• Interventions over 9 yr– Sterile CVC placement– Alcohol-based hand
hygiene– Hand hygiene campaign– ICU surveillance for
MRSA (16 months)• 29% of newly detected
MRSA carriers develop infection within 18 months
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
ICU Non-ICU Hospital
No SurveillanceActive Surveillance
Surveillance Cultures Reduce MRSA Bacteremia
Reduced ICU transmission by 47%• 43 vs. 23 cases per 1000 at risk patientsClin Infect Dis 2003;36:281-5
Clin Infect Dis 2006;43:971-8
Inci
denc
e de
nsity
per
100
0 pt
-day
s75%
40%
67%
![Page 11: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/11.jpg)
VA MRSA Initiative
N Engl J Med 2011;364:1419-30
• Decreased transmission
• Reduced HAIs• MRSA VAP• MRSA CLA-BSI• C. difficile in non-ICU• VRE in ICU and non-ICU
![Page 12: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/12.jpg)
Active Surveillance and Contact Precautions in ICU
Control Intervention
MRSA or VRE colonization or infeciton (rate per 1000 pt-days)
35.6 40.4
Days in Contact Precautions (%) 38% 51%
Hand hygiene 59% 69%
Gloves 72% 82%
Gowns 59% 77%
N Engl J Med 2011;364:1407-18
• Cluster randomized study in 18 ICUs• Surveillance cultures for MRSA and VRE - Mean delay in results 5.2 days
![Page 13: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/13.jpg)
Baseline CHG Baths P
MRSA acquisition* 5.04 3.44 0.046
VRE acquisition* 4.35 2.19 0.008
VRE bacteremia* 2.13 0.59 0.0006
Crit Care Med 2009;37:1858-1865*per 1000 pt-days
Daily Chlorhexidine Baths
![Page 14: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/14.jpg)
Chlorhexidine baths in Trauma ICU
• Before and after introduction of daily CHG baths in TICU
• In pre-contact precaution era
• Reduction in CR-BSI from 8.4 to 2.1 per 1000 catheter-days (P=0.01)
• Reduction in MRSA VAP from 5.7 to 1.6 per 1000 vent-days (P=0.03)
Arch Surg 2010;145:240-246
![Page 15: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/15.jpg)
0
4
8
12
16
20
Ra
te P
er
1,0
00
Ad
mis
sio
ns
..
0
20
40
60
80
100
MR
SA
Ca
se
s
Nosoc MRSA Cases 87 84 88 72 71 62 72 63 46 40 27 41 30 36 39 37 29
Admits 4,4894,8044,8544,5104,5434,6844,8644,6184,8635,0775,1354,8234,7604,8615,2854,9464,668
MRSA Rate 19.4 17.5 18.1 16.0 15.6 13.2 14.8 13.6 9.5 7.9 5.3 8.5 6.3 7.4 7.4 7.5 6.2
QE Mar 2007
QE Jun
2007
QE Sep 2007
QE Dec 2007
QE Mar 2008
QE Jun
2008
QE Sep 2008
QE Dec 2008
QE Mar 2009
QE Jun
2009
QE Sep 2009
QE Dec 2009
QE Mar 2010
QE Jun
2010
QE Sep 2010
QE Dec 2010
QE Mar 2011
Confidential QI
HMC Nosocomial MRSA Rates
Quarterly
Source: Infection Control, for more information, please contact Dr. Tim Dellit, [email protected]
Number of Cases2007: 331 Cases2008: 268 Cases2009: 154 Cases2010: 142 Cases
0.9 per 1000 pt-days
![Page 16: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/16.jpg)
Which of the following bundle elements is NOT correct?
A. VAP and head of bed > 30 degreesB. VAP and sedation awakeningC. VAP and DVT prophylaxisD. Central line and maximum barriers including full body drape, sterile gown, sterile gloves, mask with eye protection, and haircoverE. Central line and povidone-iodine skin prepF. Central line and hand hygiene
![Page 17: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/17.jpg)
Central Line-Associated BSI
• ICU CVC utilization 0.39 – 0.71 catheters/pt– 15 million catheter-days per year in US
• ICU rate 1.2 to 5.3 per 1000 catheter-days (NHSN mean)– 80,000 CR-BSI annually in US ICUs– Attributable mortality 0-35%
• Healthcare cost $296 million to $2.3 billion– Attributable cost $15,000-$56,000– Prolonged ICU and hospital LOS
Clin Infect Dis 2002;35:1281-307
National healthcare Safety Network (HNSN) Report, Data Summary for 2009
![Page 18: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/18.jpg)
NHSN CLA-BSI Pathogens
1986-1989 1992-1999 2006-2007
Pathogen (%) (%) (%) Coag-negative staphylococci 27 37 34Staphylococcus aureus 16 13 10*Enterococcus 8 13 16Candida sp. 8 8 12Enterobacter 5 5 4Pseudomonas aeruginosa 4 4 3Klebsiella pneumoniae 4 3 5E. Coli 6 2 3
Clin Infect Dis 2002;35:1281-307
Infect Control Hosp Epidemiol 2008;29:996-1011
*MRSA 5.6%, MSSA 4.3%
![Page 19: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/19.jpg)
Prevention of Catheter-Associated BSI
• IHI “Central Line Bundle”– Hand hygiene– Chlorhexidine skin prep– Maximal barriers
• Full drape• Mask, hair cover, sterile gown, sterile gloves
– Optimal catheter site selection– Daily review of line necessity
• Implementation AND documentation
Institute for Healthcare Improvement
![Page 20: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/20.jpg)
Bundle in Action
Reduction in mean rate from 7.7 to 1.4 per 1000 catheter-days
N Engl J Med 2006;355:2725-32
Months After Implementation
Med
ian
Blo
odst
ream
Inf
ectio
ns
per
1000
Cat
hete
r-D
ays
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Baseline 0-3 4-6 7-9 10-12 13-15 16-18
Overall
Teaching Hospital
Non-teaching Hospital
< 200 beds
> 200 beds
![Page 21: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/21.jpg)
UHC Benchmark of Key Performance Measures
Key Performance Measure Hospital Performance
Patient Level% of cases
median range
Central Venous Catheter Placed in the Subclavian Vein 44.2% 14.3 – 73.3%
Evidence of Maximal Barrier Precautions for Insertion 0.0% 0.0 – 8.2%
Hand Washing 0.0% 0.0 – 39.0%
Full Body Drape 3.0% 0.0 – 46.3%
Sterile Gloves and Gown 1.9% 0.0 – 39.0%
Cap and Mask 0.0% 0.0 – 13.6%
Chlorhexidine Skin Prep for Insertion 1.9% 0.0 – 98.1%
Daily Dressing Inspection 97.5% 25.1 – 100%
Daily Assessment of Medical Necessity to Continue CVC 16.4% 0.0 – 100%
Operational Yes % (n) Site #
Best Practice* CVC Insertion Policy 11.8% (2) 29, 89
Mandated Use of a CVC Insertion Checklist 11.8% (2) 84, 87
Infect Control Hosp Epidemiol 2008;29:440-2
![Page 22: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/22.jpg)
National Reduction in CLA-BSI
JAMA 2009;301:727-36
![Page 23: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/23.jpg)
MRSA Central Line-Associate BSI
JAMA 2009;301:727-36
50% reduction in MRSA CLA-BSI (0.43 vs 0.21 per 1000 catheter-days)
![Page 24: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/24.jpg)
Hospital-Acquired UTI
Survey of Hospital Monitoring
• 40% of healthcare-associated infections• 80% due to indwelling urethral catheter
Potential Strategies
• Insertion/care• Catheter reminders/ automatic stop orders• Bladder US scanners• Condom catheters• Antimicrobial catheters
Aymptomatic bacteriuria vs.
Symptomatic UTI in patients without localizing GU symptoms
Clin Infect Dis 2008;46:243-500
102030405060708090
100
Presence Duration UTI rates Feedback
No
mo
nito
ring
(%
)
![Page 25: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/25.jpg)
CA-UTI PathogensNHSN 2006-2007
Candida sp, 21%
Pseudomonas , 10%
Enterococcus, 15%
Klebsiella sp, 9%
Enterobacter sp, 4%
E. coli, 21%
S, aureus, 2%
Acinetobacter , 1%Coag neg
Staphylococcus, 3%
Infect Control Hosp Epidemiol 2008;29:996-1011
![Page 26: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/26.jpg)
Catheter-Associated UTI
• Duration of catheterization is primary risk
• Providers unaware of catheter status– Students 21%– Interns 22%– Residents 27%– Attendings 38%
• Daily assessment of need, especially when transferred from ICU to floor
Am J Med 2000;109:476-80
![Page 27: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/27.jpg)
Ventilator-Associated Pneumonia• Rate 0.7 – 7.4 per 1000 ventilator days (NHSN 2009)
– 10-30% of intubated patients– Incidence increases with duration of MV
• Day 1-5: 3% risk per day• Day 6-10: 2% risk per day• > 10 days: 1% risk per day
• Attributable mortality rate 33-50%• Increased LOS 7-9 days• Cost of $40,000 per patient• Accounts for 50% of ICU antimicrobials• Clinical vs. microbiologic definitions
– Poor external quality measure
Am J Respir Crit Care Med 2005;171:388-416
![Page 28: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/28.jpg)
BICU: Burn PICU: Pediatric med/surgCICU: Coronary NICU: NeurosurgeryCT ICU: Cardiothoracic SICU: SurgicalMICU: Medical TICU: Trauma
Rat
e pe
r 10
00 v
ent-
days
NHSN Pooled Mean VAP by Unit2009 Report
Am J Infect Control 2009;37:783-805
0
1
2
3
4
5
6
7
8
BICU CICU CT ICU MICU PICU NICU SICU TICU
![Page 29: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/29.jpg)
“Ventilator Bundle”
• Head of bed elevation > 30 degrees
• Daily “sedation awakening” and assessment of readiness to extubate
• Oral care (chlorhexidine)
• Peptic ulcer disease prophylaxis
• Deep vein thrombosis prophylaxis
*Institute for Healthcare Improvement
![Page 30: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/30.jpg)
Late Onset VAP Pathogens
Pathogens July 03 – June 04 (N=138)
July 08 – June 09 (N=114)
July 09 – June 10 (N=83)
Acinetobacter 44 (32%) 4 (4%) ↓ 4 (5%) ↓
MRSA 32 (23%) 8 (7%) ↓ 2 (2%) ↓
MSSA 21 (15%) 30 (26%) 23 (28%)
Haemophilus 20 (14%) 24 (21%) 13 (16%)
Pseudomonas 13 (9%) 14 (12%) 15 (18%)
Enterobacter 4 (3%) 12 (11%) 4 (5%)
Klebsiella spp. 7 (5%) 7 (6%) 5 (6%)
Serratia spp. 5 (3%) 7 (6%) 1 (1%)
E. coli 6 (4%) 6 (5%) 1 (1%)
![Page 31: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/31.jpg)
Which of the following has been demonstrated to reduce surgical site infections and is
currently part of SCIP recommendations?
A. Peri-operative prophylactic antibiotics should be given within 60 minutes after incision
B. Peri-operative prophylactic antibiotics should be given within 60 minutes before incision and discontinued within 24 hours
C. Peri-operative antibiotics should be continued until the drains are out
D. Nasal carriage of S. aureus should be eradicated prior to surgery
E. Pre-surgical bath with chlorhexidine
![Page 32: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/32.jpg)
Surgical Care Improvement Project• Implemented by CDC and Centers for Medicare and Medicaid
Services in 2002• Nationally included procedures
– Cardiothoracic, vascular, colon, hip or knee arthroplasty, vaginal or abdominal hysterectomy
• Performance measures (Baseline of 34,133 medicare patients in 2001)– Antimicrobial prophylaxis within 1 hr of incision (55.7%)– Antimicrobial agent c/w current guidelines (92.6%)– Discontinuation within 24 hours after surgery (40.7%)
• Also, clipping rather than shaving, normothermia, glucose control, morning beta-blocker, DVT prophylaxis
• Role of MRSA screening?
Arch Surg 2005;140:174-82
![Page 33: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/33.jpg)
0
1
2
3
4
≤-3 -2 -1 0 1 2 3 4 ≥5
N Engl J Med 1992;326:281-6
Perioperative Prophylactic AntibioticsTiming of Administration
Infe
ctio
ns (
%)
Hours From Incision
14/369
5/699
5/1009
2/180
1/81
1/411/47
15/441
![Page 34: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/34.jpg)
Society of Thoracic Surgeons• Rationale
– Unique patient risks• Cardiopulmonary bypass, systemic hypothermia
– Devastating sequelae of mediastinitis (7-20% mortality)– No randomized studies < 48 hrs in CT surgery
• Major Recommendations1. Postoperative prophylactic antibiotics are given for 48 hours or
less2. Duration not dependent on chest tube removal3. If risk for MRSA, then vancomycin AND cefazolin4. Routine mupirocin administration for all patients in the absence
of documented negative testing for staphylococcal colonization
Ann Thorac Surg 2006;81:397-404Ann Thorac Surg 2006;83:1569-76
![Page 35: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/35.jpg)
Is Vancomycin Alone Adequate?
S. aureus, 40%
Anaerobes, 1%Fungi, 1%
Enterococcus, 3%
Other Gram-positives, 4%
Gram-negative Bacilli, 20%
Coagulase-negative Staphylococci, 21%
No Pathogen, 4%
Unknown, 7%
Acceptable for cardiac, vascular, or orthopedic surgery:
• Beta-lactam allergy
• Documented rationale
Pathogens causing deep SSI following CABG, Hip and Knee Arthroplasty
NNIS 1994-2003
![Page 36: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/36.jpg)
Meta-analysis of Seven Randomized Studies: Glycopeptide vs. β-Lactam for Prevention of Surgical Site Infection after Cardiac Surgery
Clin Infect Dis 2004;38:1357-63
MSSA more frequent in vancomycin group 3.7% vs. 1.3%(J Thorac Cardiovasc Surg 2002;123:326-32)
![Page 37: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/37.jpg)
Intranasal Mupirocin and Surgical Site Infections
• Nasal carriage of S. aureus and risk of surgical site infection– Orthopedic surgery with prosthetic implants in 272 patients, RR 8.9
(Infect Control Hosp Epidemiol 2000;21:319-323)– Cardiothoracic surgery in 1980 patients, OR 9.6 (J
Infect Dis 1995;171:216-9)• 10/10 pre- and post-surgical pairs identical by phage typing
• Randomized, double-blind, placebo-controlled trial of pre-surgical mupirocin in 3864 patients (N Eng J Med 2002;346:1871-7)
– No difference in nosocomial infections, nosocomial S. aureus infections, or S. aureus surgical site infections
– S. aureus carriers (N=891)• 4.5 fold increase in S. aureus SSI• Significant reduction in S. aureus nosocomial infections (4.0 vs. 7.7)• Trend towards decreased S. aureus SSI (3.7 vs. 5.9, 37%, P=0.15)• Same strain in nares and site of infection in 85%
![Page 38: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/38.jpg)
Universal Screening of Surgical Patients?JAMA 2008;299:1149-57
• Prospective, cross-over study of 21,754 surgical patients– 87% on admission– MRSA colonization 5.1%
• Standard practices for all patients with MRSA– Contact precautions– Adjustment of pre-op prophylaxis– Intranasal mupirocin and chlorhexidine body wash
• No difference in MRSA SSI (0.99 vs. 1.14 per 100)– 34% of MRSA carriers did not receive appropriate pre-op
prophylaxis– None identified through outpatient screening developed MRSA
infection
![Page 39: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/39.jpg)
2% Chlorhexidine and 70% alcohol (Chloraprep) vs. 10% Povidone Iodine for Surgical-Site Antisepsis
N Engl J Med 2010;362:18-26
NNT: 17 patients
• Randomized, multi-center
• 849 patients
• Clean-contaminated surgery
![Page 40: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/40.jpg)
Pre-operative Chlorhexidine Baths
RR
Chlorhexidine vs. placebo 0.91 (0.80 to 1.04)
Chlorhexidine vs. bar soap 1.02 (0.57 to 1.84)
Chlorhexidine vs. no washing 0.36 (0.17 to 0.79)
Cochrane Review of six randomized trials with 10,007 patients
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004985. Review
![Page 41: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/41.jpg)
It’s a small world…
26 y o medical student returns April 20, 2009 from an international elective in Mexico. On April 27 she presents to ED with 4 day h/o fever 39 C, cough, HA, myalgias, and diarrhea. That same day you hear reports of a novel Influenza A virus H1N1 associated with increased mortality in Mexico.
![Page 42: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/42.jpg)
Which of the following is MOST correct regarding influenza?
A. No special precautions are necessary for patients with suspected influenza since it is not very transmissible.
B. Influenza is primarily transmitted by large droplets (> 5 microns), therefore healthcare workers should use Droplet Precautions with a surgical mask with eye protection for routine care to prevent contamination of mouth, nose, and conjunctiva.
C. Patients with 2009 H1N1 should be placed in airborne isolation with use of N-95 respirators while patients with H1N1 seasonal influenza should be placed in droplet precautions.
D. A negative rapid antigen test rules out influenza
E. Influenza vaccination of healthcare workers does not have an impact on patients.
![Page 43: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/43.jpg)
Modes of Transmission
• Droplets– Thought to be primary mode of transmission– Coughing, sneezing, and talking– Heavy; settle within 6 feet of the source
• Airborne– Related to procedures → aerosolized particles
• Contact– Direct: skin-to-skin contact– Indirect: contact with virus in the environment
![Page 44: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/44.jpg)
Respiratory Protection Debate• CDC (during 2009-2010 influenza season)
– Fit-tested N95 respirators for care of patients with 2009 H1N1– Prioritized usage if limited resources – Yet, Standard and Droplet Precautions for seasonal influenza?
• Infection Control and Infectious Diseases Societies*– No evidence that 2009 H1N1 transmitted differently than seasonal
influenza– Standard and Droplet Precautions for routine care
*Recommending organizations:• World Health Organization (WHO) • Infectious Disease Society of America• Healthcare Infection Control Practices • Society for Healthcare Epidemiology of America Advisory Committee (HICPAC) • Association of Professionals in Infection Control
![Page 45: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/45.jpg)
Surgical Mask vs. N95 RespiratorRandomized Study
Characteristic Surgical Mask
N=212
N95 Respirator
N=210
P
Vaccinated 68 (30.2%) 62 (28.1%)
Lab-confirmed*
RT-PCR
H1N1 serology
Serology without symptoms
50 (23.6%)
6 (2.8%)
17 (8.0%)
29/44 (65.9%)
48 (22.9%)
4 (1.8%)
25 (11.9%)
31/44 (70.5%)
0.86
0.75
0.18
Physician visits 13 (6.1%) 13 (6.2%) 0.98
Influenza-like illness,
Fever and cough
9 (4.2%) 2 (1.0) 0.06
Work-related absenteeism 42 (19.8%) 39 (18.6) 0.75
JAMA 2009;302:1865-71*RT-PCR or serology
![Page 46: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/46.jpg)
UW Medicine• Standard, Droplet, and Contact Precautions for routine
care– Place mask on coughing patients– Separate sick from non-sick patients– Surgical mask, eye protection, gown, and gloves
• N95 respirators for higher-risk aerosol-generating procedures– Intubation and extubation– Bronchoscopy– Open suctioning of airway– Cardiopulmonary resuscitation
Suspected or Confirmed Cases of Influenza
![Page 47: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/47.jpg)
43 y o woman from Eritrea with 3 week h/o non-productive cough, fever, and night sweats
![Page 48: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/48.jpg)
Now What?
AFB smear neg x 5 (3 sputum, 2 BAL)
Sputum AMTD neg
![Page 49: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/49.jpg)
Which of the following is the BEST approach?
A. Remove from airborne isolation as a negative AMTD test rules out infectious TB
B. Begin 4 drug therapy and remove patient from airborne isolation due to multiple negative AFB smears
C. Begin 4 drug therapy and keep in airborne isolation
D. Obtain interferon-gamma releasing assay (IGRA) as a negative result would rule out TB
![Page 50: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/50.jpg)
44 y o Vietnamese man with 6 month h/o pain and swelling of
left medial thigh associated with fevers and night sweats
![Page 51: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/51.jpg)
Pulmonary Involvement in Extrapulmonary TB
• 72 patients with XPTB 36 lymph nodes 12 pleura 6 CNS 6 GI
• 57 had sputum collection
• Weight loss associated with positive sputum cx OR 4.3 (1.01-18.72)
Chest 2008;134:589-94
49% had abnormal CXR
![Page 52: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/52.jpg)
Sputum AFB Smear
• Smear positive– 5,000-10,000 organisms per ml
of sputum must be present • Smear negative, culture-
positive TB– Responsible for roughly 17% of
TB transmission in San
Francisco and Vancouver
Am Rev Respir Dis 1966;95:998Lancet 1999;353;444, Thorax 2004;59:286
40-50% of pulmonary TB cases in King County are smear negative
![Page 53: Healthcare-Associated Infections and Infection Control Timothy H. Dellit, MD Medical Director, Infection Control Harborview Medical Center.](https://reader035.fdocuments.net/reader035/viewer/2022070307/551a8397550346e0158b4aed/html5/thumbnails/53.jpg)
Patient Safety and Infection Control
• UW Medicine Strategic Goals– Reduction in HAI– Expectation of hand hygiene with EVERY patient
EVERY the time
• WSHA elimination of HAI by 2012• Mandatory reporting of HAI
– CLA-BSI, VAP, selected surgical site infections
• MRSA legislation• Increased linkage of reimbursement to quality
– CMS preventable “medical errors”